4:00 p.m. - 4:30 p.m.

Registration

4:30 p.m. - 5:30 p.m.

Opening Keynote - Meeting the Healthcare Challenge: The Potential of Personalized, Evidence-Based Medicine
Speaker:
Mark McClellan, M.D., Ph.D., Senior Fellow, Director - Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Economic Studies, The Brookings Institution

6:00 p.m. - 7:00 p.m.

Welcome Reception – Hyatt Regency

7:00 p.m. - 9:00 p.m.

Keynote Dinner - Personalized, Evidence-Based Healthcare: Partnering for the Future
Speaker:
The Honorable W. J. Billy Tauzin, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)

8:30 a.m. - 9:00 a.m.

Registration

9:00 a.m. - 9:15 a.m.

Welcome
Speakers:
Bette Keltner, Ph.D., Dean and Professor - School of Nursing & Health Studies, Georgetown University

Wayne Rosenkrans, Jr., Ph.D., President and Chairman, PMC; Business Strategy Director – External Scientific Affairs, AstraZeneca Pharmaceuticals

9:15 a.m. - 9:40 a.m.

Keynote Address
Speaker:
The Honorable Michael O. Leavitt, Secretary of Health and Human Services, U.S. Department of Health and Human Services

9:40 a.m. – 10:00 a.m.

Q&A with Secretary Leavitt

10:00 a.m. – 10:45 a.m.

Panel 1 – Setting the Stage for Common Goals
Speakers:
Carolyn Clancy, M.D., Director, Agency for Healthcare Research and Quality

Janet Woodcock, M.D., Deputy Commissioner and Chief Medical Officer, Food and Drug Administration

Dan Mendelson, M.P.P., President and Founder, Avalere Health

Moderator:
Charles Evans, M.D., Ph.D., Chair – Department of Human Sciences – School of Nursing & Health Studies, Georgetown University

10:45 a.m. – 11:15 a.m.

Moderated Discussion with Panel 1

11:15 a.m. – 11:30 a.m.

Break

11:30 a.m. – 12:15 p.m.

Panel 2 – Evidence-Based Medicine: The Impact of Personalized Medicine
Speakers:
Raymond Woosley, M.D., Ph.D., President and Chief Executive Officer, The Critical Path Institute (C-Path Institute)

Julie DeLoia, Ph.D., Associate Dean of Academic Affairs – School of Nursing & Health Studies, Georgetown University

George Poste, D.V.M., Ph.D., D.Sc., F.R.S., Director, Del E. Webb Distinguished Professor of Biology, and Regents’ Professor, The Biodesign Institute at Arizona State University

Moderator:
Cole Werble, Editor-in-Chief, The RPM Report

12:15 p.m. – 12:45 p.m.

Moderated discussion with Panel 2

12:45 p.m. – 1:00 p.m.

Break

1:00 p.m. – 1:45 p.m.

Lunch – Hyatt Regency

1:45 p.m. – 2:05 p.m.

Introduction:
Speaker:
Mara Aspinall, Vice Chair, PMC; President, Genzyme Genetics

Keynote Luncheon - Pharmacogenomics: Potential for Improving the Outcomes of Clinical Practice
Speaker:
Kevin FitzGerald, S.J., Ph.D., The Dr. David Lauler Chair in Catholic Health Care Ethics, Georgetown University Medical Center; Chairman - Pharmacogenomics Task Force, Secretary's Advisory Committee on Genetics, Health, and Society

2:05 p.m. – 2:20 p.m.

Q&A with Keynote

2:20 p.m. – 2:35 p.m.

Break

2:35 p.m. – 3:20 p.m.

Panel 3 – Personalized Medicine: The Impact of Evidence-Based Medicine
Speakers:
Michael McGinnis, M.D., M.P.P., Senior Scholar, Institute of Medicine

Richard Platt, M.D., M.S., Professor - Ambulatory Care and Prevention, Professor of Medicine, Harvard Medical School; Principal Investigator - CDC Center of Excellence in Public Health Informatics

Jennifer Bright, M.P.A., Director, National Working Group on Evidence-Based Health Care; Executive Director, Society for Healthcare Epidemiology of America (SHEA)

Moderator:
Barbara J. Culliton, Contributing Editor, Health Affairs

3:20 p.m. – 3:50 p.m.

Moderated discussion with Panel 3

3:50 p.m. – 4:20 p.m.

Closing Address - Where Do We Go From Here?
Speakers:
Dan Roden, M.D., Professor – Medicine and Pharmacology, Director – Oates Institute for Experimental Therapeutics, Assistant Vice-Chancellor for Personalized Medicine, Vanderbilt University School of Medicine

Lewis Sandy, M.D., Senior Vice President – Clinical Advancement, United Health Group

Moderator:
Gregory Downing, D.O., Ph.D., Project Director – Personalized Health Care Initiative, Department of Health and Human Services

4:20 p.m. – 4:35 p.m.

Closing Remarks
Speakers:
Bette Keltner, Ph.D., Dean and Professor – School of Nursing & Health Studies, Georgetown University

Wayne Rosenkrans, Jr., Ph.D., President and Chairman, PMC; Business Strategy Director - External Scientific Affairs, AstraZeneca Pharmaceuticals